Cargando…
Clinical Effects of Gemifloxacin on the Delay of Tuberculosis Treatment
Although gemifloxacin has low in vitro activity against Mycobacterium tuberculosis, the effect of gemifloxacin on the delay of tuberculosis (TB) treatment has not been validated in a clinical setting. The study group included patients with culture-confirmed pulmonary TB who initially received gemifl...
Autores principales: | Kim, Seo Yun, Yim, Jae-Joon, Park, Jong Sun, Park, Sung Soo, Heo, Eun Young, Lee, Chang-Hoon, Chung, Hee Soon, Kim, Deog Kyeom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594600/ https://www.ncbi.nlm.nih.gov/pubmed/23486643 http://dx.doi.org/10.3346/jkms.2013.28.3.378 |
Ejemplares similares
-
The Association of BCG Vaccination with Atopy and Asthma in Adults
por: Park, Sung Soo, et al.
Publicado: (2015) -
In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea.
por: Yong, Dong Eun, et al.
Publicado: (2002) -
The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study
por: Song, Jin Hwa, et al.
Publicado: (2019) -
Chest computed tomography scan as an initial diagnostic method for tuberculosis infection detected by mass screening
por: Joo, Dong-Hyun, et al.
Publicado: (2021) -
Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2017)